A 72-year-old woman presents with a 15-year history of a gradually enlarging brown patch on her right temple. On examination, the lesion is 3.5 cm in diameter, with ill-defined borders, and predominantly brown coloration with areas of darker pigmentation. Dermoscopy reveals a lacy reticular pattern with follicular openings. Excision biopsy shows melanoma with a Breslow thickness of 0.8 mm, Clark level II invasion, no ulceration, and 0 mitoses per mm². What is the most likely subtype, and what is the most significant prognostic advantage in this case?

## Clinical Diagnosis: Lentigo Maligna Melanoma (LMM) ### Subtype Identification **Key Point:** Lentigo maligna melanoma arises from a pre-existing lentigo maligna (in situ melanoma) on chronically sun-exposed skin, typically the face and ears, in elderly patients. It is characterized by a **very long history** (years to decades) and slow growth. The clinical presentation in this case is classic for LMM: - **Age:** 72 years (elderly patient) - **Location:** Right temple (chronically sun-exposed area) - **Duration:** 15-year history (very long, slow growth) - **Clinical appearance:** Ill-defined borders, predominantly brown with darker areas (lentigo maligna appearance) - **Dermoscopy:** Lacy reticular pattern with follicular openings (characteristic of lentigo maligna) - **Histology:** Breslow thickness 0.8 mm, Clark level II (superficial invasion) ### Prognostic Advantage: Early Detection **High-Yield:** The most significant prognostic advantage in LMM is that the **long pre-malignant phase (lentigo maligna stage)** allows for early detection and diagnosis at a thin, superficial stage. This results in: | Feature | Prognostic Impact | |---------|------------------| | **Long history (years to decades)** | Allows time for clinical recognition and biopsy before deep invasion | | **Superficial growth pattern** | Typically remains thin (Breslow <1 mm) at diagnosis | | **Lower mitotic rate** | Reflects slower biological behavior | | **Excellent 5-year survival** | ~90–95% when diagnosed at thin stage | **Clinical Pearl:** LMM has the **best prognosis** among all melanoma subtypes when diagnosed early, despite its location on the face (typically considered a high-risk site). The 15-year history allowed time for the lesion to be recognized and biopsied before deep invasion occurred. ### Breslow Thickness and Stage The Breslow thickness of 0.8 mm places this patient in **Stage IA** (AJCC 2017), which carries >95% 5-year survival. However, this excellent prognosis is not unique to LMM—any melanoma <1 mm would have similar survival rates. The **distinguishing feature of LMM is the long pre-malignant phase**, which is the reason for early detection. ### Why Not Other Subtypes? - **Superficial spreading melanoma (SSM):** Presents with a shorter history (months to a few years); more common overall but not specific to elderly patients or the face. - **Nodular melanoma (NM):** Presents as a raised nodule; more aggressive; shorter history; higher mitotic rate; worse prognosis. - **Acral lentiginous melanoma (ALM):** Occurs on palms, soles, or subungual areas; not on the face.